7.63
Arvinas Inc 주식(ARVN)의 최신 뉴스
Where Arvinas Stands With Analysts - Benzinga
Arvinas (ARVN) Sees Analyst Downgrade and Significant Price Target Cut | ARVN Stock News - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, ... - Bluefield Daily Telegraph
Arvinas, Inc. (NASDAQ:ARVN) Short Interest Up 21.0% in April - MarketBeat
ARVN: BMO Capital Maintains Rating While Lowering Price Target | ARVN Stock News - GuruFocus
Arvinas (NASDAQ:ARVN) Posts Quarterly Earnings Results, Beats Estimates By $2.07 EPS - MarketBeat
Arvinas, Inc. (NASDAQ:ARVN) Shares Bought by ArrowMark Colorado Holdings LLC - MarketBeat
Arvinas (ARVN) Target Price Lowered by Citi Amid Pipeline Developments | ARVN Stock News - GuruFocus
Citi cuts Arvinas stock price target to $9.50, keeps neutral rating - Investing.com India
Truist Downgrades Arvinas to Hold From Buy, Cuts Price Target to $11 From $21 - marketscreener.com
Arvinas (ARVN) Downgraded by Truist Amid Market Concerns | ARVN Stock News - GuruFocus
Arvinas stock rating cut, price target slashed to $11 at Truist - Investing.com Australia
Arvinas, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your RightsARVN - ACCESS Newswire
Arvinas: Yet Another Biotech Trading Below Net Cash, But It's Only A Mild Bull Case - Seeking Alpha
Piper Sandler Reiterates Overweight Rating for Arvinas (NASDAQ:ARVN) - MarketBeat
Arvinas (NASDAQ:ARVN) Price Target Cut to $16.00 by Analysts at Barclays - MarketBeat
HC Wainwright Cuts Arvinas (NASDAQ:ARVN) Price Target to $24.00 - MarketBeat
Arvinas (NASDAQ:ARVN) Lowered to Hold Rating by TD Cowen - MarketBeat
Arvinas, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates - Yahoo Finance
Jefferies Financial Group Reaffirms "Hold" Rating for Arvinas (NASDAQ:ARVN) - MarketBeat
Boxer Capital Management LLC Makes New Investment in Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat
Arvinas, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud AllegationsARVN - ACCESS Newswire
Arvinas, Inc. (NASDAQ:ARVN) Shares Bought by Barclays PLC - MarketBeat
Arvinas (ARVN) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Price T Rowe Associates Inc. MD Has $78.66 Million Stock Holdings in Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat
Schonfeld Strategic Advisors LLC Has $12.58 Million Stock Holdings in Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat
Renaissance Technologies LLC Lowers Stock Position in Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat
Brokerages Set Arvinas, Inc. (NASDAQ:ARVN) Price Target at $34.33 - MarketBeat
Arvinas, Inc. (ARVN) Shareholders May Have Been Affected by FraudLevi & Korsinsky Investigates - ACCESS Newswire
Arvinas stock rating cut to hold at TD Cowen after trial cancellations - Investing.com India
Arvinas Earnings Call: Clinical Progress and Strategic Shifts - TipRanks
BTIG cuts Arvinas stock price target to $16 from $69 By Investing.com - Investing.com South Africa
Levi & Korsinsky Announces an Investigation on Behalf of Arvinas, Inc. (ARVN) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
Arvinas (ARVN) Stock: Wells Fargo Lowers Price Target to $19 | ARVN Stock News - GuruFocus
Arvinas (ARVN) Faces Price Target Cut Amid Strategic Adjustments | ARVN Stock News - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
Arvinas price target lowered to $10 from $20 at BMO Capital - TipRanks
Arvinas (ARVN) Target Price Lowered by Goldman Sachs | ARVN Stock News - GuruFocus
Guggenheim Maintains Buy Rating but Lowers Price Target for ARVN | ARVN Stock News - GuruFocus
Arvinas price target lowered to $14 from $24 at Piper Sandler - TipRanks
Arvinas price target lowered to $16 from $69 at BTIG - TipRanks
Arvinas (ARVN): Piper Sandler Adjusts Price Target Amid Reiteration of Rating | ARVN Stock News - GuruFocus
Barclays Analyst Lowers Price Target for Arvinas (ARVN) by 50% | ARVN Stock News - GuruFocus
Arvinas (ARVN) Price Target Reduced Following Strategic Restruct - GuruFocus
Arvinas Holding Company: Buy Rating Affirmed Amidst Promising Vepdeg Potential and Strong Financial Position - TipRanks
ARVN: HC Wainwright & Co. Adjusts Price Target While Maintaining Buy Rating | ARVN Stock News - GuruFocus
Here are 1 Main Capital Partners’ Views on Arvinas (ARVN) - Insider Monkey
Arvinas (ARVN) Price Target Reduced Following Strategic Restructuring | ARVN Stock News - GuruFocus
Jefferies Downgrades Arvinas (ARVN) with Significant Price Targe - GuruFocus
Arvinas (ARVN) Experiences Price Target Reduction Amid Developme - GuruFocus
Arvinas price target lowered to $16 from $32 at Guggenheim - TipRanks
Arvinas (ARVN) Experiences Price Target Reduction Amid Development Shift | ARVN Stock News - GuruFocus
Jefferies Downgrades Arvinas (ARVN) with Significant Price Target Cut | ARVN Stock News - GuruFocus
Wells Fargo Adjusts Target Price for Arvinas (ARVN) Stock | ARVN - GuruFocus
Arvinas (ARVN) Price Target Slashed by Analyst Amid Strategic Sh - GuruFocus
Jefferies Downgrades Arvinas to Hold From Buy, Adjusts Price Target to $10 From $52 - marketscreener.com
TD Cowen Downgrades Arvinas to Hold From Buy - marketscreener.com
Arvinas (ARVN) Price Target Slashed by Analyst Amid Strategic Shift | ARVN Stock News - GuruFocus
Arvinas (ARVN) Price Target Reduced as Key Drug Trials Progress | ARVN Stock News - GuruFocus
Arvinas (ARVN) Downgraded to Hold Amid Vepdeg Combo Trial Cancellation | ARVN Stock News - GuruFocus
Arvinas Reports First Quarter 2025 Financial Results and Provides Corporate Update | ARVN Stock News - GuruFocus
BTIG cuts Arvinas stock price target to $16 from $69 - Investing.com
Barclays Adjusts Price Target for Arvinas (ARVN), Maintains Positive Outlook | ARVN Stock News - GuruFocus
Arvinas Inc (ARVN) Q1 2025 Earnings Call Highlights: Record Revenue Surge and Strategic ... - Yahoo Finance
2,208,234 Shares in Arvinas, Inc. (NASDAQ:ARVN) Purchased by T. Rowe Price Investment Management Inc. - MarketBeat
자본화:
|
볼륨(24시간):